These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 19222190)

  • 1. Quantitative detection of HIV-1 particles using HIV-1 neutralizing antibody-conjugated beads.
    Kim BC; Ju MK; Dan-Chin-Yu A; Sommer P
    Anal Chem; 2009 Mar; 81(6):2388-93. PubMed ID: 19222190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS/HIV. A boost for HIV vaccine design.
    Burton DR; Weiss RA
    Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
    Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; Nanlohy NM; van Baarle D; van Nuenen AC; Hessell AJ; Schuitemaker H
    J Gen Virol; 2010 May; 91(Pt 5):1354-64. PubMed ID: 20053822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies.
    Zhou N; Fan L; Ho HT; Nowicka-Sans B; Sun Y; Zhu Y; Hu Y; McAuliffe B; Rose B; Fang H; Wang T; Kadow J; Krystal M; Alexander L; Colonno R; Lin PF
    Virology; 2010 Jul; 402(2):256-61. PubMed ID: 20400170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY; Hariharan K; Posner MR; Nara P
    J Immunol; 1993 Jul; 151(1):449-57. PubMed ID: 7686944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: synthesis and cancer cell targeting and sorting.
    Di Corato R; Bigall NC; Ragusa A; Dorfs D; Genovese A; Marotta R; Manna L; Pellegrino T
    ACS Nano; 2011 Feb; 5(2):1109-21. PubMed ID: 21218823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the fluorescence of dye-antibody conjugates by (2-hydroxypropyl)-β-cyclodextrin in fluorescence microscopy and flow cytometry.
    Guryev O; Abrams B; Lomas C; Nasraty Q; Park E; Dubrovsky T
    Anal Chem; 2011 Sep; 83(18):7109-14. PubMed ID: 21846137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study provides insight into HIV-neutralizing antibody evolution via deep-sequencing and structural analysis.
    Expert Rev Vaccines; 2011 Oct; 10(10):1369. PubMed ID: 22102990
    [No Abstract]   [Full Text] [Related]  

  • 13. Engineered viral nanoparticles for flow cytometry and fluorescence microscopy applications.
    Robertson KL; Liu JL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(5):511-24. PubMed ID: 22700447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of nanoparticles for the detection and sorting of pathogenic bacteria by flow-cytometry.
    Zahavy E; Ber R; Gur D; Abramovich H; Freeman E; Maoz S; Yitzhaki S
    Adv Exp Med Biol; 2012; 733():23-36. PubMed ID: 22101709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum dot-based HIV capture and imaging in a microfluidic channel.
    Kim YG; Moon S; Kuritzkes DR; Demirci U
    Biosens Bioelectron; 2009 Sep; 25(1):253-8. PubMed ID: 19665685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based flow virometry for the analysis of individual virions.
    Arakelyan A; Fitzgerald W; Margolis L; Grivel JC
    J Clin Invest; 2013 Sep; 123(9):3716-27. PubMed ID: 23925291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic particles as liquid carriers in the microfluidic lab-in-tube approach to detect phase change.
    Blumenschein NA; Han D; Caggioni M; Steckl AJ
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8066-72. PubMed ID: 24827028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researchers characterize target of broadly neutralizing antibody PG9.
    IAVI Rep; 2011; 15(6):15. PubMed ID: 22351963
    [No Abstract]   [Full Text] [Related]  

  • 19. High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.
    Bonar MM; Tilton JC
    Virology; 2017 May; 505():80-90. PubMed ID: 28235684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetically functionalized retroviruses produced from the bioorthogonally engineered cell surface.
    Wong S; Kwon YJ
    Bioconjug Chem; 2011 Feb; 22(2):151-5. PubMed ID: 21280590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.